4//SEC Filing
Browne L Daniel 4
Accession 0001479290-19-000018
CIK 0001479290other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:02 PM ET
Size
7.9 KB
Accession
0001479290-19-000018
Insider Transaction Report
Form 4
Browne L Daniel
DirectorCEO and President
Transactions
- Award
Common Stock
2019-01-24+35,000→ 177,543 total - Award
Employee Stock Option (Right to Buy)
2019-01-24+200,000→ 200,000 totalExercise: $17.23Exp: 2029-01-23→ Common Stock (200,000 underlying)
Holdings
- 409(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Mr. Browne's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]These shares are held by the Dan and Brenda Browne Living Trust. Mr. Browne is a Trustee of the Dan and Brenda Browne Living Trust.
- [F3]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 24, 2019, subject to Mr. Browne's Continuous Service (as defined in the Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001597583
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 9:02 PM ET
- Size
- 7.9 KB